Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kay Beharry

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Prostaglandins & Other Lipid Mediators|March 4, 2003
Antenatal administration of celecoxib, a selective cyclooxygenase (COX)-2 inhibitor, appears to improve placental perfusion in the pregnant rabbitNicole Hausman, Kay Beharry, Kenji Nishihara, et al.
Prostaglandins & Other Lipid Mediators|March 4, 2003
In vitro response of prostaglandin E2 receptor (EP3) in the term pregnant rat uterus and cervix to misoprostolCecilia Lyons, Kay Beharry, Yasir Akmal, et al.
American Journal of Obstetrics and Gynecology|January 8, 2004
Response of fetal prostanoids, nitric oxide, and ductus arteriosus to the short- and long-term antenatal administration of celecoxib, a selective cyclo-oxygenase-2 inhibitor, in the pregnant rabbitNicole Hausman, Kay Beharry, Kenji Nishihara, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|September 30, 2010
Caffeine impact on neonatal morbiditiesJacob V Aranda, Kay Beharry, Gloria B Valencia, et al.
American Journal of Obstetrics and Gynecology|March 5, 2005
Dose response of RU486 in a novel rabbit model of noninfectious preterm birth: comparative efficacy of 3 routes of administrationDavid Gorenberg, Kay Beharry, Kenji C Nishihara, et al.
Prostaglandins & Other Lipid Mediators|November 14, 2002
Differential regulation of prostacyclin and thromboxane by dexamethasone and celecoxib during oxidative stress in newborn rabbitsNaomi Ozaki, Kay Beharry, Kenji C Nishihara, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Prostaglandins & Other Lipid Mediators|March 4, 2003
Antenatal administration of celecoxib, a selective cyclooxygenase (COX)-2 inhibitor, appears to improve placental perfusion in the pregnant rabbitNicole Hausman, Kay Beharry, Kenji Nishihara, et al.
Prostaglandins & Other Lipid Mediators|March 4, 2003
In vitro response of prostaglandin E2 receptor (EP3) in the term pregnant rat uterus and cervix to misoprostolCecilia Lyons, Kay Beharry, Yasir Akmal, et al.
American Journal of Obstetrics and Gynecology|January 8, 2004
Response of fetal prostanoids, nitric oxide, and ductus arteriosus to the short- and long-term antenatal administration of celecoxib, a selective cyclo-oxygenase-2 inhibitor, in the pregnant rabbitNicole Hausman, Kay Beharry, Kenji Nishihara, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|September 30, 2010
Caffeine impact on neonatal morbiditiesJacob V Aranda, Kay Beharry, Gloria B Valencia, et al.
American Journal of Obstetrics and Gynecology|March 5, 2005
Dose response of RU486 in a novel rabbit model of noninfectious preterm birth: comparative efficacy of 3 routes of administrationDavid Gorenberg, Kay Beharry, Kenji C Nishihara, et al.
Prostaglandins & Other Lipid Mediators|November 14, 2002
Differential regulation of prostacyclin and thromboxane by dexamethasone and celecoxib during oxidative stress in newborn rabbitsNaomi Ozaki, Kay Beharry, Kenji C Nishihara, et al.
Pageof 1